Reliability of major bleeding events in UK routine data vs clinical trial adjudicated follow-up data
Journal article
MAFHAM M. et al, (2023), Heart
Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2023), The Lancet
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
Journal article
PARISH S. et al, (2023), Trials
Data provenance and integrity of health-care systems data for clinical trials.
Journal article
Murray ML. et al, (2022), Lancet Digit Health, 4, e567 - e568
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Journal article
LANDRAY M. et al, (2022), The Lancet
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Preprint
RECOVERY Collaborative Group None. et al, (2022)
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2022)
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Horby PW. et al, (2021), Lancet Respiratory Medicine, 9, 1419 - 1426
Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
Journal article
Keng MJ. et al, (2021), Value in Health
What is the association of COVID-19 with heart attacks and strokes?
Other
Mafham M. and Baigent C., (2021), Lancet, 398, 561 - 563
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19.
Journal article
Pessoa-Amorim G. and Mafham MM., (2021), Cardiovasc Res, 117, e110 - e113
Making trials part of good clinical care: lessons from the RECOVERY trial
Journal article
Pessoa-Amorim G. et al, (2021), Future Healthcare Journal, 8, e243 - e250
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2021)
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2021)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
A biomarker-based biological age in UK Biobank: composition and prediction of mortality and hospital admissions.
Journal article
Chan MS. et al, (2021), J Gerontol A Biol Sci Med Sci
Dexamethasone in hospitalized patients with covid-19
Journal article
Horby P. et al, (2021), New England Journal of Medicine, 384, 693 - 704
Place and Underlying Cause of Death During the COVID-19 Pandemic: Retrospective Cohort Study of 3.5 Million Deaths in England and Wales, 2014 to 2020.
Journal article
Wu J. et al, (2021), Mayo Clin Proc